Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The rapid evolution of treatment strategies for hepatitis C.

The American journal of gastroenterology - 1 May 2014

Muir Andrew J

Abstract excerpt

Hepatitis C virus (HCV) treatment took a major step forward at the end of 2013 with the approvals of the second-generation protease inhibitor simeprevir (Olysio) and the nucleotide polymerase inhibitor sofosbuvir (Sovaldi). The interferon-free regimen of sofosbuvir and ribavirin is now available for genotype 2 and 3 patients. This regimen for 12 weeks is highly effective for genotype 2, whereas genotype 3 has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Administration Schedule
Share to Heterocyclic Compounds, 3-Ring
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ribavirin

Share to Simeprevir

Share to Sofosbuvir

Share to Sulfonamides

Share to Uridine Monophosphate

Source

Identifiers

PMID: 24732866
DOI: 10.1038/ajg.2014.66

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The rapid evolution of treatment strategies for hepatitis C.PMID 24732866Read ↗

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.Semantic proximity Read ↗

The management of hepatitis C.Semantic proximity Read ↗

Current and emerging therapeutic approaches to hepatitis C infection.Semantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

Management of chronic hepatitis C in 2017.Semantic proximity Read ↗

Diagnosis and Management of Hepatitis C.Semantic proximity Read ↗

A review of standard and newer treatment strategies in hepatitis C.Semantic proximity Read ↗

The evolving treatment of chronic hepatitis C: where we stand a decade out.Semantic proximity Read ↗

JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2Semantic proximity Read ↗

Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C.Semantic proximity Read ↗

[Hepatitis C].Semantic proximity Read ↗

Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.